Objective To observe the effectiveness and safety of calcium-containing dialysate and replacement fluid with regional citrate anticoagulation in continuous renal replacement treatment (CRRT). Methods We prospectively recruited the patients treated with CRRT in West China Hospital of Sichuan University during January 2020 to December 2021. They were treated with the model of continuous veno-venous hemodiafiltration (CVVHDF) using citrate anticoagulation method. Blood access used the cuffed catheter in internal jugular vein or femoral vein. The initial blood flow was 150 ml/min, the rate of calcium-containing dialysate and replacement fluid was 1,000 ml/h, and 4% sodium citrate solution was pumped at the initial rate of 180 ml/h. Calcium ion was measured before and after the filtration at 0h, 6h, 12h, 24h and 48h. Lifespan of the extracorporeal circulation pipeline, treatment parameters and complications were collected. Results A total of 28 patients were enrolled in this study, including 44 times of extracorporeal circulation pipeline and 42 times of scheduled CRRT. The average lifespan of the extracorporeal circulation pipeline was 44.0±24.6h, including the lifespan of <24h in 11 cases (26.2%), 24h ～ ＜48h in 13 cases (31.0%), and 48h ～≤72h in 18 cases (42.9%). There were no significant differences in the levels of calcium ion before filtration at 6h (t=0.612, P=0.969), 12h (t=0.456, P=0.625), 24h (t=0.848, P=0.298) and 48h (t=0.411, P=0.415), as compared with the baseline level at 0h. There were also no significant differences in the levels of calcium ion after filtration at 6h (t=0.294, P=0.774), 12h (t=0.246, P=0.405), 24h (t=0.191, P=0.853) and 48h (t=0.059, P=0.955), as compared with the level at 0h. Metabolic alkalosis was found in one patient (2.3%), and citric acid accumulation was found in one patient (2.3%). Conclusion The calcium-containing dialysate and replacement fluid with regional citrate anticoagulation for CRRT is effective and safe, and is suitable for the use of CRRT equipment with integrated citrate anticoagulation system. This method is worthy of further clinical application.
QIANG Jing-Ya
,
TANG Xue
,
WANG Fang
,
WANG Bei-Bei
,
CHEN Zhi-Wen
,
CHEN Fang
,
ZHANG Ling
. Prospective study of calcium-containing dialysate and replacement fluid with simplified citrate anticoagulation technique in continuous renal replacement treatment[J]. Chinese Journal of Blood Purification, 2025
, 24(01)
: 31
-34
.
DOI: 10.3969/j.issn.1671-4091.2025.01.006
[1] 付平. 连续性肾脏替代治疗[M]. 北京: 人民卫生出版社, 2016: 3.
[2] Ronco C. Evolution of technology for continuous renal replacement therapy: forty years of improvements[J]. Contrib Nephrol, 2017,189: 114-123.
[3]Anantharaman S, Chionh CY. Correcting hyponatremia by fluid sodium modulation in continuous renal replacement therapy with regional citrate anticoagulation[J]. Semin Dial. 2022 Mar;35(2):198-203.
[4] Rhee H, Berenger B, Mehta RL, et al. Regional citrate anticoagulation for continuous kidney replacement therapy with calcium-containing solutions: A cohort study[J]. Am J Kidney Dis, 2021,78(4) 550-559.
[5]席春生,刘同存,蔡蕊莲等.含钙透析液和置换液局部枸橼酸抗凝连续静脉静脉血液透析滤过临床观察[J].中国血液净化,2022,21(08):576-579.
[6]Tiantian W,Xin T,Ling Z, et al. Calcium-containing versus calcium-free replacement solution in regional citrate anticoagulation for continuous renal replacement therapy: a randomized controlled trial[J]. Chinese Medical Journal,2022,135(20).
[7]Zhang L, Liao Y, Xiang J, Qin W, Wu X, Tang Y, et al. Simplified regional citrate anticoagulation using a calcium-containing replace ment solution for continuous venovenous hemofiltration. J Artif Organs 2013;16:185–192.
[8]Ong SC, Wille KM, Speer R, Tolwani AJ. A continuous veno venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid. Int J Artif Organs 2014;37:499–502.
[9]张凌,李佩芸,魏甜甜等.简化枸橼酸抗凝技术在持续缓慢低效血液透析中的临床应用[J].华西医学,2018,33(07):838-842.
[10]?Kaewdoungtien P, Tachaboon S, Kangsumrith N, Srisawat N. Immunomodulation Effect of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Renal Replacement Therapy[J]. Blood Purif. 2023;52(5):474-482.?
[11]?Legrand M, Tolwani A. Anticoagulation strategies in continuous renal replacement therapy[J]. Semin Dial. 2021 Nov;34(6):416-422.?
[12] 董晓辉,徐岩.连续性肾脏替代治疗置换液的应用现状[J].齐鲁医学杂志,2011,26(04):374-376.
[13] Bianchi NA, Altarelli M, Eckert P, Schneider AG. Complications of Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy: An Observational Study[J]. Blood Purif. 2020;49(5):567-575.?
[14]韩锦, 王欣, 李侠,等 . 枸橼酸盐两段式抗凝在含钙置换液连续性肾脏替代治疗中的抗凝效果[J]. 山西医科大学学报, 2019,50(12):1750-1754.
[15]Kirwan CJ, Hutchison R, Ghabina S, Schwarze S, Beane A, Ramsay S, Thompson E, Prowle JR. Implementation of a Simplified Regional Citrate Anticoagulation Protocol for Post-Dilution Continuous Hemofiltration Using a Bicarbonate Buffered, Calcium Containing Replacement Solution[J]. Blood Purif. 2016;42(4):349-355.?
